Drug intelligence / Profile preview

Soulagel

Development stage
Phase 3
Lead developer
Laboratoire Phytotech
Administration
Topical
01

Overview

Soulagel is a topical herbal gel developed for the management of acute musculoskeletal pain and soft tissue injuries. The formulation is composed of a synergistic blend of natural active ingredients, including menthol, camphor, and essential oils such as eucalyptus, rosemary, and lavender. It functions as a topical analgesic and anti-inflammatory agent, providing a cooling sensation and localized pain relief by targeting transient receptor potential (TRP) channels. Soulagel has been evaluated in clinical trials, notably by researchers at the Université de Monastir in Tunisia, as a potential alternative to topical non-steroidal anti-inflammatory drugs (NSAIDs) like piroxicam for patients presenting with acute extremity pain.

Brand names
Soulagel
02

Targets

TRPV1 (Transient receptor potential cation channel subfamily V member 1)TRPM8 (Transient receptor potential cation channel subfamily M member 8)TRPA1 (Transient receptor potential cation channel subfamily A member 1)

Beyond the preview

Go deeper on Soulagel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Soulagel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call